Advanced Search
FENG Bin, LV Li-yan, LIU Xi-bin, SONG Li-hua, SONG Xian-rang. Clinical Significance to Detect Lunx mRNA of Pre- and Post- chemotherapy in Peripheral Blood of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2009, 36(08): 669-672. DOI: 10.3971/j.issn.1000-8578.2009.08.011
Citation: FENG Bin, LV Li-yan, LIU Xi-bin, SONG Li-hua, SONG Xian-rang. Clinical Significance to Detect Lunx mRNA of Pre- and Post- chemotherapy in Peripheral Blood of Non-small Cell Lung Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2009, 36(08): 669-672. DOI: 10.3971/j.issn.1000-8578.2009.08.011

Clinical Significance to Detect Lunx mRNA of Pre- and Post- chemotherapy in Peripheral Blood of Non-small Cell Lung Cancer Patients

More Information
  • Received Date: July 21, 2008
  • Revised Date: January 12, 2009
  • Objective To detect the expression of Lunx mRNA in circulating tumor cells in peripheral blood of no small cell lung cancer (NSCLC) patients with metaphase and advanced stage and to investigate the effect and clinical significance of chemotherapy on circulating tumor cells. Methods Sixty-three patients with NSCLC of metaphase and advanced stage were treated with platinum based chemotherapy. Lunx mRNA of their peripheral blood prior and posterior to the first course and the second course chemotherapy was detected and the curative effect after 2 cycles of chemotherapy was evaluated. Peripheral blood of 10 patients with pulmonary benign lesions and 10 healthy volunteers was used as control. Results The positive rate of Lunx mRNA in NSCLC patients was 73.02% before chemotherapy, and in the control group was zero. The expression of Lunx mRNA had no close correlation with age, gender, pathological types and performance status score, and was closely related to clinical stages(P=0.05). After two cycles of chemotherapy,the patients reached CR, PR, SD and PD were 0,21,23,16 respectively. The positive rates of NSCLC patients after first and second cycles of chemotherapy were both 38.33%,which was significant decreased compared with those before therapy(P=0.00). The expression rates of Lunx mRNA in patients with PR, SD and PD were 23.81%, 26.09% and 75.00% respectively. The positive rates of PR and SD were significantly decreased compared with that prior to therapy (P=0.01 and P=0.00, respectively). But the positive rates of PD was similar to that of prior treatment (P=0.65). Conclusion Lunx mRNA was a favourable tumor marker to predict micrometastases in NSCLC patients. Lunx mRNA expression in peripheral blood was highly correlated with clinical stage of NSCLC patients. The positive rate of circulating tumor cells in peripheral blood was markedly decreased in patients with PR or SD, rather than that with PD. The descent of positive rate was not a course-depended.It suggests that the detection of Lunx mRNA in peripheral blood should be able to optimize therapeutic strategies.
  • Related Articles

    [1]XIAO Jincheng, GUO Leiming, KANG Xinxin, BAI Qiwen, ZHANG Junling, LI Jing. Comparison of Efficiency and Safety Between Radiofrequency Ablation and Stereotactic Body Radiotherapy on Primary Small Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 831-835. DOI: 10.3971/j.issn.1000-8578.2017.17.0613
    [2]LU Sicong, LU Haiming, LIU Lei, JIANG Shuiming, ZHANG Qishun. Emergency Transcatheter Arterial Embolization Combined with Two-stage Liver Resection for Spontaneous Ruptured Hepatocellular Carcinoma: A Systematic Review[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 997-1000. DOI: 10.3971/j.issn.1000-8578.2015.10.010
    [3]LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
    [4]Shen Xinying, Zhang Yanfang, Kong Jian, Dou Yongchong, Li Yong, Cai Jinzhong, He Fan, Chen Xudong. Therapeutic Value of Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma with Arterioportal Shunts[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1120-1124. DOI: 10.3971/j.issn.1000-8578.2012.09.016
    [5]PENG Qi-rong, XIAO Bi, ZHANG Jian, CHENG Tao, CHEN Guo-qiang. Percutaneous Microwave Coagultion Therapy Influence on Hepatofibrosis of Primary Hepatocellular Carcinoma Serum[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 322-323. DOI: 10.3971/j.issn.1000-8578.2011.03.022
    [6]HUANG Jin-qiu, PENG Min-hao, ZOU Quan-qing, YANG Ding-hua, CHEN Bin, XIAO Kai-yin. Cox Model Analysis of Prognostic Factors after Radical Hepatectomy for Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(02): 137-139. DOI: 10.3971/j.issn.1000-8578.2009.02.015
    [8]MA Guoan. RFA Combined with TACE for Primary Hepatic Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(12): 905-907. DOI: 10.3971/j.issn.1000-8578.3352
    [9]SONG Bin, WANG Wei-xing, ZHANG Wen, et al. Effect of the different combined therapy methods of transcatheter arterial chemoembolization (TACE) and percutaneous radio-frequency ablation(RF) on the elder patients with unresectable hepatocellular carcinoma(HCC)[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 496-497. DOI: 10.3971/j.issn.1000-8578.2920
    [10]Jiang Xiao-Qing, Yin Guang-fu, Su Ka-qing, Wang Hao. Study on apoptosis of hepatocellular carcinoma cells after intrahepatic arterial angiotensin Ⅱ infusion induced hypertension and chemoembolization (IHCE )[J]. Cancer Research on Prevention and Treatment, 1996, 23(6): 350-351.

Catalog

    Article views (2267) PDF downloads (569) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return